Autor: |
Lee MS; Cardiovascular Intervention Center, Cedars-Sinai Medical Center, 8631 W. Third St., Room 415E, Los Angeles, CA 90048, USA. michaelslee@pol.net, Wilentz JR, Makkar RR, Singh V, Nero T, Swistel D, Belsley SJ, Simon C, Rametta S, DeRose J |
Jazyk: |
angličtina |
Zdroj: |
The Journal of invasive cardiology [J Invasive Cardiol] 2004 Aug; Vol. 16 (8), pp. 419-25. |
Abstrakt: |
Hybrid revascularization (HR) combines staged percutaneous coronary intervention (PCI) on stenoses in the non-left anterior descending (LAD) territories with minimally invasive direct coronary artery bypass (MIDCAB) using the left internal thoracic artery (LITA) to the LAD. The LITA-to-LAD graft, which has a 5-year patency rate of 95%, is the major determinant of the long-term survival for patients. Thus, HR aims to perform full revascularization without compromising the survival advantage of the LITA-to-LAD graft, while preserving the minimally invasive advantages associated with the percutaneous treatment of symptomatic coronary stenoses. We investigated whether HR was a valid alternative to conventional coronary artery bypass graft surgery in patients with multivessel coronary artery disease. We also present our early experiences with HR using a combined approach of advanced PCI and robotically-assisted MIDCAB. |
Databáze: |
MEDLINE |
Externí odkaz: |
|